Skip to content
The Los Angeles

Personalized mRNA cancer vaccine shows promise in extending life span in melanoma trial

Personalized mRNA cancer vaccine shows promise in extending life span in melanoma trial
Photo: ABC7 Los Angeles (KABC) · view original

Merck and Moderna announced Wednesday that a personalized mRNA-based cancer vaccine succeeded in a large, late-stage trial among high-risk patients with melanoma.

Sources and story details